Form 8-K

8-K — Fusemachines Inc.

Accession: 0001493152-26-042767

Filed: 2026-09-15

Period: 2026-09-10

CIK: 0002033383

SIC: 7373 (SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN)

Item: Entry into a Material Definitive Agreement

Item: Unregistered Sales of Equity Securities

Item: Financial Statements and Exhibits

Documents

8-K — form8-k.htm (Primary)

EX-10.1 (ex10-1.htm)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K

8-K (Primary)

Filename: form8-k.htm · Sequence: 1

false

0002033383

2026-09-10

0002033383

FUSE:CommonStockParValue0.0001PerShareMember

2026-09-10

0002033383

FUSE:WarrantsToPurchaseSharesOfCommonStockMember

2026-09-10

iso4217:USD

xbrli:shares

iso4217:USD

xbrli:shares

UNITED

STATES

SECURITIES

AND EXCHANGE COMMISSION

Washington,

D.C. 20549

FORM

8-K

CURRENT

REPORT

Pursuant

to Section 13 or 15(d)

the Securities Exchange Act of 1934

Date

of Report (date of earliest event reported) September 10, 2026

FUSEMACHINES

INC.

(Exact

name of registrant as specified in its charter)

Delaware

001-42909

98-1602789

(State

or other jurisdiction of

incorporation

or organization)

(Commission

File

Number)

(I.R.S.

Employer

Identification

Number)

200

West 41st Street, 21st Floor

New

York, New York 10036

(Address

of principal executive offices and zip code)

(347)

212-5075

(Registrant’s

telephone number, including area code)

Check

the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under

any of the following provisions:

☐

Written

communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting

material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement

communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement

communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities

registered pursuant to Section 12(b) of the Act:

Title

of each class

Trading

symbol(s)

Name

of each exchange on which registered

Common

Stock, par value $0.0001 per share

FUSE

Nasdaq

Stock Market LLC

Warrants

to purchase shares of Common Stock

FUSEW

Nasdaq

Stock Market LLC

Indicate

by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405

of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging

growth company ☒

an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying

with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item

1.01 Entry

into a Material Definitive Agreement.

The

information set forth in Item 3.02 of this Current Report on Form 8-K is incorporated herein by reference.

Item

3.02 Unregistered

Sales of Equity Securities.

September 10, 2026, Fusemachines Inc., a Delaware corporation (the “Company”), entered into a Securities Purchase Agreement

(the “Purchase Agreement”) with certain vendors and service providers of the Company (collectively, the “Purchasers”).

Pursuant to the Purchase Agreement, the Company agreed to issue and sell to the Purchasers an aggregate of up to 2,138,935 shares

(the “Shares”) of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), in satisfaction

of an aggregate of approximately $1.30 million in accrued and unpaid fees and other amounts owed by the Company to the Purchasers

(the “Accrued Fees”).

The

per share purchase price for the Shares is $0.6103 (the “Per Share Purchase Price”), which was calculated as the volume-weighted

average price (“VWAP”) of the Common Stock on The Nasdaq Global Market for the five (5) consecutive trading days ending on

and including the trading day immediately preceding the closing date (the “Closing Date”). The number of Shares issuable

to each Purchaser equals the quotient of (a) such Purchaser’s Accrued Fees divided by (b) the Per Share Purchase Price, rounded

down to the nearest whole share. No cash consideration was received by the Company; the sole consideration for the Shares was the satisfaction

and cancellation of the Accrued Fees. The Company anticipates that the Shares will be issued on or about September 14, 2026.

The

Shares were offered and sold in reliance upon the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933,

as amended (the “Securities Act”) and Rule 506(b) of Regulation D promulgated thereunder.

Pursuant

to the Purchase Agreement, the Company has agreed to file a registration statement on Form S-3 (or Form S-1 if Form S-3 is not available)

with the Securities and Exchange Commission (the “SEC”) for the resale of the Shares by the Purchasers as soon as practicable

following the Closing Date, and to use commercially reasonable efforts to cause such registration statement to become effective within

90 days following the Closing Date.

The

Purchase Agreement contains customary representations and warranties by the Company and the Purchasers, indemnification provisions, and

other terms and conditions.

The

foregoing description of the Purchase Agreement does not purport to be complete and is qualified in its entirety by reference to the

full text of the Purchase Agreement, the form of which is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated

herein by reference.

Cautionary

Note Regarding Forward-Looking Statements

This

Current Report on Form 8-K contains forward-looking statements within the meaning of Section 27A of the Securities Act, and Section 21E

of the Securities Exchange Act of 1934, as amended. These forward-looking statements involve known and unknown risks, uncertainties and

other factors that may cause the Company’s actual results, performance, or achievements to be materially different from any future

results, performance, or achievements expressed or implied by the forward-looking statements. In some cases, forward-looking statements

can be identified by terms such as “may,” “will,” “should,” “expect,” “plan,”

“anticipate,” “could,” “intend,” “target,” “project,” “believe,”

“estimate,” “potential,” or “continue” or the negative of these terms or other similar expressions.

Forward-looking statements are based on the Company’s current expectations and assumptions about future events. The Company undertakes

no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise,

except as required by law.

Item

9.01 Financial

Statements and Exhibits.

(d)

Exhibits.

Exhibit

No.

Description

10.1

Form of Securities Purchase Agreement, dated as of September 10, 2026, by and between Fusemachines Inc. and the Purchasers named therein (filed herewith).

104

Cover

Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

Pursuant

to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by

the undersigned hereunto duly authorized.

FUSEMACHINES INC.

Date: September 15, 2026

By:

/s/

Sameer Maskey

Name:

Sameer

Maskey

Title:

Chief

Executive Officer

EX-10.1

Filename: ex10-1.htm · Sequence: 2

Exhibit

10.1

SECURITIES

PURCHASE AGREEMENT

This

Securities Purchase Agreement (this “Agreement”) is dated as of September 10, 2026, between Fusemachines Inc., a Delaware

corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, a “Purchaser”

and collectively, the “Purchasers”).

WHEREAS,

subject to the terms and conditions set forth in this Agreement and pursuant to an exemption from the registration requirements of Section

5 of the Securities Act of 1933, as amended (the “Securities Act”), in Section 4(a)(2) thereof and/or Regulation D

promulgated thereunder, the Company desires to issue and sell to each Purchaser, and each Purchaser desires to purchase from the Company,

the Shares (as defined below) in satisfaction of the Accrued Fees owed by the Company to such Purchaser, as more fully described in this

Agreement.

NOW,

THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt

and adequacy of which are hereby acknowledged, the Company and the Purchasers agree as follows:

Article

DEFINITIONS

1.1

Definitions. In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms

have the meanings set forth in this Section 1.1:

“Accrued

Fees” shall mean, with respect to each Purchaser, the aggregate unpaid fees and other amounts due and owing to such Purchaser

by the Company as set forth on such Purchaser’s signature page.

“Affiliate”

means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control

with a Person as such terms are used in and construed under Rule 405 under the Securities Act.

“Board

of Directors” means the board of directors of the Company.

“Business

Day” means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or any day

on which banking institutions in the State of New York are authorized or required by law or other governmental action to close.

“Closing”

means the closing of the purchase and sale of the Shares pursuant to Section 2.1.

“Closing

Date” means the Trading Day on which all the Transaction Documents have been executed and delivered by the parties thereto

and all conditions precedent to the Company’s obligations to deliver the Shares have been satisfied or waived, but in no event

later than the second (2nd) Trading Day following the date hereof.

“Commission”

means the United States Securities and Exchange Commission.

“Common

Stock” means the common stock of the Company, par value $0.0001 per share, and any other class of securities into which such

securities may hereafter be reclassified or changed.

“Exchange

Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

“GAAP”

shall have the meaning ascribed to such term in Section 3.1(f).

“Lien”

means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.

“Material

Adverse Effect” shall have the meaning assigned to such term in Section 3.1(a).

“Per

Share Purchase Price” means an amount equal to the volume-weighted average price (VWAP) of the Common Stock on the Trading

Market for the five (5) consecutive Trading Days ending on and including the Trading Day immediately preceding the Closing Date, subject

to adjustment for reverse and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common

Stock that occur after the date of this Agreement and prior to the Closing Date.

“Person”

means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability

company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

“Proceeding”

means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding,

such as a deposition), whether commenced or threatened.

“Purchaser

Party” shall have the meaning ascribed to such term in Section 4.5.

“Registrable

Securities” means the Shares issued at Closing. Notwithstanding the foregoing, the Shares shall cease to be Registrable Securities

for all purposes hereunder upon the earlier to occur of the following: (A) the sale by any Person of such Shares to the public either

pursuant to a registration statement under the Securities Act or Rule 144 (in which case, only such Shares sold shall cease to be Registrable

Securities) or (B) such Shares become eligible for sale by non-Affiliates without volume or manner-of-sale restrictions pursuant to Rule

144, without the requirement for the Company to be in compliance with the current public information requirement under Rule 144, as determined

in good faith by the Company.

“Required

Approvals” shall have the meaning ascribed to such term in Section 3.1(d).

“Rule

144” means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted

from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect

as such Rule.

“SEC

Reports” shall have the meaning ascribed to such term in Section 3.1(f).

“Securities”

means, with respect to each Purchaser, the Shares sold or issuable to such Purchaser pursuant to this Agreement.

“Shares”

means the shares of Common Stock issued or issuable to each Purchaser pursuant to this Agreement.

“Short

Sales” means all “short sales” as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not be

deemed to include locating and/or borrowing shares of Common Stock).

“Subscription

Amount” means, with respect to each Purchaser, the amount set forth on such Purchaser’s signature page.

“Subsidiary”

means any subsidiary of the Company as set forth on Exhibit 21.1 to the Annual Report on Form 10-K filed with the Commission on March

27, 2026.

“Trading

Day” means a day on which the principal Trading Market is open for trading.

“Trading

Market” means The Nasdaq Global Market (or any successor thereto), on which the Common Stock is listed or quoted for trading

under the symbol “FUSE”.

“Transaction

Documents” means this Agreement and any other documents or agreements executed in connection with the transactions contemplated

hereunder.

“Transfer

Agent” means Continental Stock Transfer & Trust Company, the current transfer agent of the Company, with a mailing address

of 1 State Street, 30th Floor, New York, NY 10014, and any successor transfer agent of the Company.

Article

II.

PURCHASE AND SALE

2.1

Closing. On the Closing Date, upon the terms and subject to the conditions set forth herein, the Company agrees to sell to each

Purchaser, and each Purchaser agrees to purchase from the Company, the number of shares of Common Stock set forth on such Purchaser’s

signature page (the “Shares”) in exchange for the satisfaction of the Accrued Fees of such Purchaser. The Company

and each Purchaser shall deliver the other items set forth in Section 2.2 deliverable at the Closing. Upon satisfaction of the covenants

and conditions set forth in Sections 2.2 and 2.3, the Closing shall occur at the offices of the Company, such other location as the parties

may mutually agree, or remotely by electronic transmission. The number of Shares set forth on each Purchaser’s signature page is

equal to the quotient of (a) the Accrued Fees of such Purchaser and (b) the Per Share Purchase Price, rounded down to the nearest whole

share of Common Stock.

2.2

Deliveries; Satisfaction of Accrued Fees.

(a)

On or prior to the Closing Date, the Company shall deliver or cause to be delivered to each Purchaser the following:

(i)

this Agreement duly executed by the Company; and

(ii)

a copy of irrevocable instructions to the Transfer Agent instructing the Transfer Agent to deliver the Shares in book-entry form registered

in the name of such Purchaser.

(b)

On or prior to the Closing Date, each Purchaser shall deliver or cause to be delivered to the Company this Agreement duly executed by

such Purchaser.

(c)

Upon receipt by each Purchaser of the Shares pursuant to subsection (a) above, the Accrued Fees for such Purchaser shall be deemed paid

and satisfied in full.

2.3

Closing Conditions.

(a)

The obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met:

(i)

the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse

Effect, in all respects) when made and on the Closing Date of the representations and warranties of each Purchaser contained herein (unless

as of a specific date therein in which case they shall be accurate as of such date);

(ii)

all obligations, covenants and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have been

performed; and

(iii)

the delivery by each Purchaser of the item set forth in Section 2.2(b) of this Agreement.

(b)

The obligations of each Purchaser hereunder in connection with the Closing are subject to the following conditions being met:

(i)

the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse

Effect, in all respects) when made and on the Closing Date of the representations and warranties of the Company contained herein (unless

as of a specific date therein in which case they shall be accurate as of such date);

(ii)

all obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been performed;

and

(iii)

the delivery by the Company of the items set forth in Section 2.2(a) of this Agreement.

Article

III.

REPRESENTATIONS AND WARRANTIES

3.1

Representations and Warranties of the Company. Except as set forth in the SEC Reports, which SEC Reports shall be deemed a part

hereof and shall qualify any representation or otherwise made herein to the extent of the disclosure contained in the SEC Reports, the

Company hereby makes the following representations and warranties to each Purchaser:

(a)

Organization and Qualification. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized,

validly existing and in good standing under the laws of the jurisdiction of its incorporation or organization (if a good standing concept

exists in such jurisdiction), with the requisite power and authority to own and use its properties and assets and to carry on its business

as currently conducted. Neither the Company nor any Subsidiary is in material violation nor default of any of the provisions of its respective

certificate or articles of incorporation, bylaws or other organizational or charter documents. Each of the Company and the Subsidiaries

is duly qualified to conduct business and is in good standing as a foreign corporation or other entity in each jurisdiction in which

the nature of the business conducted or property owned by it makes such qualification necessary (if a good standing concept exists in

such jurisdiction), except where the failure to be so qualified or in good standing, as the case may be, could not have or reasonably

be expected to result in: (i) a material adverse effect on the legality, validity or enforceability of any Transaction Document, (ii)

a material adverse effect on the results of operations, assets, business, prospects or condition (financial or otherwise) of the Company

and the Subsidiaries, taken as a whole, or (iii) a material adverse effect on the Company’s ability to perform in any material

respect on a timely basis its obligations under any Transaction Document (any of (i), (ii) or (iii), a “Material Adverse Effect”);

provided, however, that in no event shall any of the following individually or taken together, be deemed to constitute, or be taken into

account in determining whether a Material Adverse Effect has occurred or could be reasonably expected to occur: (i) any change in the

Company’s stock price or trading volume on the Trading Market, (ii) any failure by the Company to meet internal or analyst revenue,

earnings or other financial projections or expectations for any period, (iii) any effect that results from changes affecting the industry

in which the Company operates, or the United States economy generally, or any effect that results from changes affecting general worldwide

economic or United States or global capital market conditions, (iv) any effect caused by the announcement of the transactions contemplated

by this Agreement or the other Transaction Documents, or the identity of any Purchaser or any of its Affiliates as a Purchaser in connection

with the transactions contemplated by this Agreement, (v) political conditions, including acts of war or terrorism or natural disasters

or any pandemic or epidemic, including COVID-19, (vi) any action taken or omitted to be taken by the Company at the written request or

with the prior written consent of any Purchaser, or (vii) changes in any law, rule, regulation, order, judgment, injunction, decree or

other binding directive issued by any governmental, judicial or self-regulatory entity or interpretations or enforcement thereof. No

Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail such

power and authority or qualification.

(b)

Authorization; Enforcement. The Company has the requisite corporate power and authority to enter into and to consummate the transactions

contemplated by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder.

The execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation by it of

the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company and no

further action is required by the Company, the Board of Directors or the Company’s stockholders in connection herewith or therewith

other than in connection with the Required Approvals. This Agreement and each other Transaction Document to which it is a party has been

(or upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms hereof and thereof, will

constitute the valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except (i) as

limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application

affecting enforcement of creditors’ rights generally, (ii) as limited by laws relating to the availability of specific performance,

injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable

law.

(c)

No Conflicts. The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to

which it is a party, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby and thereby

do not and will not (i) conflict with or violate any provision of the Company’s or any Subsidiary’s certificate or articles

of incorporation, bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a default (or an event that

with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties or

assets of the Company or any Subsidiary, or give to others any rights of termination, amendment, anti-dilution or similar adjustments,

acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument

(evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by

which any property or asset of the Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict

with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or

governmental authority to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations),

or by which any property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and

(iii), such as could not have or reasonably be expected to result in a Material Adverse Effect.

(d)

Filings, Consents and Approvals. The Company is not required to obtain any consent, waiver, authorization or order of, give any

notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or other

Person in connection with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i) any filing

required pursuant to Section 4.4 of this Agreement, (ii) application(s) to the Trading Market for the listing of the Shares for trading

thereon in the time and manner required thereby, and (iii) if applicable, the filing of Form D with the Commission and such filings as

are required to be made under applicable state securities laws (collectively, the “Required Approvals”).

(e)

Issuance of the Securities. The Securities are duly authorized and, when issued in accordance with the applicable Transaction

Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company. The Company

is authorized to issue 500,000,000 shares of Common Stock and has reserved from its duly authorized capital stock the maximum number

of shares of Common Stock issuable pursuant to this Agreement.

(f)

SEC Reports; Financial Statements. The Company has filed all reports, schedules, forms, statements and other documents required

to be filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the

two years preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such material) (the

foregoing materials, including the exhibits thereto and documents incorporated by reference therein, being collectively referred to herein

as the “SEC Reports”) on a timely basis or has received a valid extension of such time of filing and has filed any

such SEC Reports prior to the expiration of any such extension. As of their respective dates, the SEC Reports complied in all material

respects with the requirements of the Securities Act and the Exchange Act, as applicable, and none of the SEC Reports, when filed, contained

any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make

the statements therein, in the light of the circumstances under which they were made, not misleading. The Company has never been an issuer

subject to Rule 144(i) under the Securities Act. The financial statements of the Company included in the SEC Reports comply in all material

respects with applicable accounting requirements and the rules and regulations of the Commission with respect thereto as in effect at

the time of filing. Such financial statements have been prepared in accordance with United States generally accepted accounting principles

applied on a consistent basis during the periods involved (“GAAP”), except as may be otherwise specified in such financial

statements or the notes thereto and except that unaudited financial statements may not contain all footnotes required by GAAP, and fairly

present in all material respects the financial position of the Company and its consolidated Subsidiaries as of and for the dates thereof

and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial,

year-end audit adjustments.

(g)

Acknowledgment Regarding Purchasers’ Purchase of Securities. The Company acknowledges and agrees that each Purchaser is

acting solely in the capacity of an arm’s length purchaser with respect to the Transaction Documents and the transactions contemplated

thereby. The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company (or in any similar

capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any advice given by any Purchaser or

any of its representatives or agents in connection with the Transaction Documents and the transactions contemplated thereby is merely

incidental to such Purchaser’s purchase of the Securities. The Company further represents to each Purchaser that the Company’s

decision to enter into this Agreement and the other Transaction Documents has been based solely on the independent evaluation of the

transactions contemplated hereby by the Company and its representatives.

(h)

No Disqualification Events. With respect to the Securities to be offered and sold hereunder in reliance on Rule 506 under the

Securities Act, none of the Company, any of its predecessors, any affiliated issuer, any director, executive officer, other officer of

the Company participating in the offering hereunder, or, to the knowledge of the Company, any beneficial owner (as that term is defined

in Rule 13d-3 under the Exchange Act) of 20% or more of the Company’s outstanding voting equity securities, calculated on the basis

of voting power, nor any promoter (as that term is defined in Rule 405 under the Securities Act) connected with the Company in any capacity

at the time of sale is subject to any of the “Bad Actor” disqualifications described in Rule 506(d)(1)(i) to (viii) under

the Securities Act (a “Disqualification Event”), except for a Disqualification Event covered by Rule 506(d)(2) or (d)(3).

The Company has exercised reasonable care to determine whether any Issuer Covered Person is subject to a Disqualification Event. The

Company has complied, to the extent applicable, with its disclosure obligations under Rule 506(e), and has furnished to the Purchasers

copies of any disclosures provided thereunder.

3.2

Representations and Warranties of the Purchasers. Each Purchaser, severally and not jointly and severally, hereby represents and

warrants as of the date hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein, in which case

they shall be accurate as of such date):

(a)

Organization; Authority. Each Purchaser that is an entity is duly incorporated or formed, validly existing and in good standing

under the laws of the jurisdiction of its incorporation or formation, and each Purchaser that is an individual has full legal capacity,

in each case with full right, corporate, partnership, limited liability company or similar power and authority to enter into and to consummate

the transactions contemplated by the Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The execution

and delivery of the Transaction Documents and performance by each Purchaser of the transactions contemplated by the Transaction Documents

have been duly authorized by all necessary corporate, partnership, limited liability company or similar action, as applicable, on the

part of each Purchaser. Each Transaction Document to which a Purchaser is a party has been duly executed by such Purchaser, and when

delivered by such Purchaser in accordance with the terms hereof, will constitute the valid and legally binding obligation of such Purchaser,

enforceable against such Purchaser in accordance with its terms, except: (i) as limited by general equitable principles and applicable

bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors’ rights

generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies

and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.

(b)

Understandings or Arrangements. Each Purchaser is acquiring the Securities as principal for its own account and has no direct

or indirect arrangement or understanding with any other Person to distribute or regarding the distribution of such Securities (this representation

and warranty not limiting such Purchaser’s right to sell the Securities in compliance with applicable federal and state securities

laws). Specifically, each Purchaser understands that the Securities are “restricted securities” and have not been registered

under the Securities Act or any other applicable state securities law.

(c)

Status of Each Purchaser. At the time each Purchaser was offered the Securities, such Purchaser was, and as of the date hereof

such Purchaser is, either: (i) an “accredited investor” as defined in Rule 501(a) under the Securities Act or (ii) a “qualified

institutional buyer” as defined in Rule 144A(a) under the Securities Act.

(d)

Experience of Each Purchaser. Each Purchaser, either alone or together with its representatives, has such knowledge, sophistication

and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment

in the Securities, and has so evaluated the merits and risks of such investment. Each Purchaser is able to bear the economic risk of

an investment in the Securities and, at the present time, is able to afford a complete loss of such investment.

(e)

Access to Information; Representation. Each Purchaser acknowledges that it, and its chosen counsel if applicable, have had the

opportunity to review the Transaction Documents (including all exhibits and schedules thereto) and the SEC Reports and has been afforded,

(i) the opportunity to ask such questions as it has deemed necessary of, and to receive answers from, representatives of the Company

concerning the terms and conditions of the offering of the Securities and the merits and risks of investing in the Securities; (ii) access

to information about the Company and its financial condition, results of operations, business, properties, management and prospects sufficient

to enable it to evaluate its investment; and (iii) the opportunity to obtain such additional information that the Company possesses or

can acquire without unreasonable effort or expense that is necessary to make an informed investment decision with respect to the investment.

Each Purchaser further acknowledges that it has been afforded the opportunity to be represented by counsel of its choosing in connection

with this offering.

(f)

Confidentiality. Each Purchaser has maintained the confidentiality of all disclosures made to such Purchaser in connection with

this Agreement (including the existence and terms of this Agreement), other than disclosures to such Purchaser’s representatives,

including, without limitation, its officers, directors, partners, legal and other advisors, employees, agents and Affiliates.

(g)

No General Solicitation. No Purchaser is purchasing the Securities as a result of any registration statement, advertisement, article,

notice or other communication regarding the Securities published in any newspaper, magazine or similar media or broadcast over television

or radio or presented at any seminar or any other general solicitation or general advertisement.

Article

IV.

OTHER AGREEMENTS OF THE PARTIES

4.1

Removal of Legends.

(a)

The Securities may only be disposed of in compliance with state and federal securities laws. In connection with any transfer of Securities

other than pursuant to an effective registration statement with a current prospectus, or to the Company, the Company may require the

transferor thereof to provide to the Company an opinion of counsel at the expense of the transferor, selected by the transferor and reasonably

acceptable to the Company, the form and substance of which opinion shall be reasonably satisfactory to the Company, to the effect that

such transfer does not require registration of such transferred Securities under the Securities Act.

(b)

Each Purchaser agrees that, so long as is required by this Section 4.1, book-entry notations evidencing the Shares held by such Purchaser

shall bear a restrictive legend, substantially in the following form:

THE

SHARES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”) AND ARE

“RESTRICTED SECURITIES” AS DEFINED IN RULE 144 PROMULGATED UNDER THE ACT. THE SHARES MAY NOT BE OFFERED, SOLD, PLEDGED, OR

OTHERWISE DISTRIBUTED OR TRANSFERRED EXCEPT (i) PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT OR (ii) PURSUANT TO AN

EXEMPTION FROM REGISTRATION UNDER THE ACT, AND, IN THE CASE OF A TRANSACTION EXEMPT FROM REGISTRATION, UNLESS THE COMPANY AND THE TRANSFER

AGENT HAVE RECEIVED AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO EACH OF THEM THAT SUCH TRANSACTION DOES NOT REQUIRE REGISTRATION

UNDER THE ACT.

(c)

The book-entry ledger of the Transfer Agent evidencing the Shares shall not contain any legend (including the legend set forth in Section

4.1(b) hereof): (i) while a registration statement with a current prospectus covering the resale of such Shares is effective under the

Securities Act, (ii) following any sale of such Shares pursuant to Rule 144, (iii) if such Shares are eligible for sale under Rule 144,

without the requirement for the Company to be in compliance with the current public information requirement under Rule 144 as to such

Shares and without volume or manner-of-sale restrictions or (iv) if such legend is not required under applicable requirements of the

Securities Act (including judicial interpretations and pronouncements issued by the staff of the Commission) (“Effective Date”).

The Company shall cause its counsel (which may be counsel to a Purchaser) to issue a legal opinion to the Transfer Agent promptly after

the Effective Date if required by the Transfer Agent to effect the removal of the legend hereunder. If such Shares may be sold under

Rule 144 without limitation or restriction and the Company is then in compliance with the current public information requirement under

Rule 144, or if the Shares may be sold under Rule 144 without the requirement for the Company to be in compliance with the current public

information requirement under Rule 144 as to such Shares or if such legend is not otherwise required under applicable requirements of

the Securities Act (including judicial interpretations and pronouncements issued by the staff of the Commission) then such Shares shall

be issued free of all legends. The Company agrees that following the Effective Date and at such time as such legend is no longer required

under this Section 4.1(c), it will, no later than the number of Trading Days comprising the Standard Settlement Period (as defined below)

following the delivery by a Purchaser to the Company or the Transfer Agent of a book-entry position representing Shares issued with a

restrictive legend, deliver or cause to be delivered to such Purchaser a book-entry position representing such Shares that is free from

all restrictive and other legends. The Company may not make any notation on its records or give instructions to the Transfer Agent that

enlarge the restrictions on transfer set forth in this Section. Book-entry positions for Shares subject to legend removal hereunder shall

be transmitted by the Transfer Agent to the applicable Purchaser by crediting the account of such Purchaser’s prime broker with

the Depository Trust Company System as directed by such Purchaser. “Standard Settlement Period” means the standard

settlement period, expressed in a number of Trading Days, on the Company’s primary Trading Market with respect to the Shares as

in effect on the date of delivery of a book-entry position representing the Shares.

4.2

Furnishing of Information. Until the earlier of (i) the date that no Purchaser owns any Shares or (ii) the two-year anniversary

of the Closing Date, the Company shall use reasonable efforts to timely file all reports required to be filed by the Company after the

date hereof pursuant to the Exchange Act even if the Company is not then subject to the reporting requirements of the Exchange Act; provided,

however, that this covenant shall not prevent a sale, merger or similar transaction involving the Company.

4.3

Integration. The Company shall use reasonable efforts not to sell, offer for sale or solicit offers to buy or otherwise negotiate

in respect of any security (as defined in Section 2 of the Securities Act) that would be integrated with the offer or sale of the Shares

for purposes of the rules and regulations of any Trading Market such that it would require shareholder approval prior to the closing

of such other transaction unless shareholder approval is obtained before the closing of such subsequent transaction.

4.4

Securities Laws Disclosure; Publicity. The Company, if required under applicable rules, shall file a Current Report on Form 8-K

(or other appropriate form under the Exchange Act), including this Agreement as an exhibit thereto, with the Commission within the time

required by the Exchange Act.

4.5

Indemnification of Purchasers. Subject to the provisions of this Section 4.5, the Company will indemnify and hold each Purchaser

and its directors, officers, shareholders, members, partners, employees and agents (and any other Persons with a functionally equivalent

role of a Person holding such titles notwithstanding a lack of such title or any other title), each Person who controls any Purchaser

(within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, shareholders,

agents, members, partners or employees (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding

a lack of such title or any other title) of such controlling persons (each, a “Purchaser Party”) harmless from any

and all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in

settlements, court costs and reasonable attorneys’ fees and costs of investigation that any such Purchaser Party may suffer or

incur as a result of or relating to (a) any breach of any of the representations, warranties, covenants or agreements made by the Company

in this Agreement or in the other Transaction Documents or (b) any action instituted against any Purchaser Party in any capacity, or

any of them or their respective Affiliates, by any stockholder of the Company who is not an Affiliate of such Purchaser Party, with respect

to any of the transactions contemplated by the Transaction Documents (unless such action is solely based upon a material breach of such

Purchaser Party’s representations, warranties or covenants under the Transaction Documents or any agreements or understandings

such Purchaser Party may have with any such stockholder or any violations by such Purchaser Party of state or federal securities laws

or any conduct by such Purchaser Party which is finally judicially determined to constitute fraud, gross negligence or willful misconduct).

If any action shall be brought against any Purchaser Party in respect of which indemnity may be sought pursuant to this Agreement, such

Purchaser Party shall promptly notify the Company in writing, and the Company shall have the right to assume the defense thereof with

counsel of its own choosing reasonably acceptable to such Purchaser Party. Any Purchaser Party shall have the right to employ separate

counsel in any such action and participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense

of such Purchaser Party except to the extent that (x) the employment thereof has been specifically authorized by the Company in writing,

(y) the Company has failed after a reasonable period of time to assume such defense and to employ counsel or (z) in such action there

is, in the reasonable opinion of counsel to the Company, a material conflict on any material issue between the position of the Company

and the position of such Purchaser Party, in which case the Company shall be responsible for the reasonable fees and expenses of no more

than one such separate counsel. The Company will not be liable to any Purchaser Party under this Agreement (1) for any settlement by

a Purchaser Party effected without the Company’s prior written consent, which shall not be unreasonably withheld or delayed; or

(2) to the extent, but only to the extent that a loss, claim, damage or liability is attributable to any Purchaser Party’s breach

of any of the representations, warranties, covenants or agreements made by such Purchaser Party in this Agreement or in the other Transaction

Documents. The indemnification required by this Section 4.5 shall be made by periodic payments of the amount thereof during the course

of the investigation or defense, as and when bills are received or are incurred. The indemnity agreements contained herein shall be in

addition to any cause of action or similar right of any Purchaser Party against the Company or others and any liabilities the Company

may be subject to pursuant to law.

4.6

Listing of Common Stock. The Company hereby agrees to use commercially reasonable efforts to maintain the listing or quotation

of the Common Stock on the Trading Market on which it is currently listed, and concurrently with the Closing, the Company shall apply

to list or quote all the Shares on the Trading Market and promptly secure the listing of all the Shares on the Trading Market. The Company

further agrees, if the Company applies to have the Common Stock traded on any other Trading Market, it will then include in such application

all the Shares and will take such other action as is necessary to cause all the Shares to be listed or quoted on such other Trading Market

as promptly as possible. The Company will then take all action reasonably necessary to continue the listing and trading of its Common

Stock on a Trading Market and will comply in all respects with the Company’s reporting, filing and other obligations under the

bylaws or rules of the Trading Market.

4.7

Form D; Blue Sky Filings. The Company agrees, if required by applicable law or rules, to timely file a Form D with respect to

the Shares as required under Regulation D and to provide a copy thereof, promptly upon request of any Purchaser.

4.8

Certain Transactions and Confidentiality. No Purchaser or any Affiliate acting on behalf of a Purchaser or pursuant to an understanding

with a Purchaser will execute any purchases or sales, including Short Sales, of any of the Company’s securities during the period

commencing with the execution of this Agreement and ending at such time that the transactions contemplated by this Agreement are first

publicly announced pursuant to the Current Report on Form 8-K as described in Section 4.4. Each Purchaser covenants that, so long as

such Purchaser holds any Shares purchased pursuant to this Agreement, such Purchaser shall not engage in Short Sales of the Company’s

securities. Each Purchaser covenants that, until such time as the transactions contemplated by this Agreement are publicly disclosed

by the Company pursuant to the Current Report on Form 8-K as described in Section 4.4, such Purchaser will maintain the confidentiality

of the existence and terms of this Agreement.

4.9

Registration Statement.

(a)

As soon as practicable (and in any event no later than September 30, 2026), the Company shall file a registration statement on Form S-3

(or Form S-1 if Form S-3 is not available) providing for the resale by the Purchasers of the Registrable Securities. The Company shall

use commercially reasonable efforts to cause such registration statement to become effective within 90 days following the Closing Date

and to keep such registration statement effective at all times until no Purchaser owns any Registrable Securities.

(b)

No Purchaser may assign its rights under this Section 4.9 unless such assignment is approved in writing by the Company, in the Company’s

sole discretion.

Article

MISCELLANEOUS

5.1

Termination. This Agreement may be terminated by any Purchaser if the Closing has not been consummated on or before the fifth

(5th) Trading Day following the date hereof; provided, however, that no such termination will affect the right of any party to sue for

any breach by any other party or parties.

5.2

Fees and Expenses. Each party shall pay the fees and expenses of its advisers, counsel, accountants, and other experts, if any,

and all other expenses incurred by such party incident to the negotiation, preparation, execution, delivery and performance of this Agreement.

The Company shall pay all Transfer Agent fees (including, without limitation, any fees required for same-day processing of any instruction

letter delivered by the Company), stamp taxes and other taxes and duties levied in connection with the delivery of any Shares to the

Purchasers.

5.3

Entire Agreement. The Transaction Documents, together with the exhibits and schedules thereto contain the entire understanding

of the parties with respect to the subject matter hereof and thereof and supersede all prior agreements and understandings, oral or written,

with respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.

5.4

Notices. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in

writing and shall be deemed given and effective on the earliest of: (a) the time of transmission, if such notice or communication is

delivered via facsimile at the facsimile number or email attachment at the email address set forth on the applicable signature page at

or prior to 5:30 p.m. (New York City time) on a Trading Day, (b) the next Trading Day after the time of transmission, if such notice

or communication is delivered via facsimile at the facsimile number or email attachment at the email address set forth on the applicable

signature page on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (c) the second (2nd)

Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service or (d) upon actual receipt

by the party to whom such notice is required to be given. Notices to the Company shall be addressed as follows: Fusemachines Inc., 200

West 41st Street, 21st Floor, New York, New York 10036, Attention: Chief Executive Officer, Email: smaskey@fusemachines.com. Notices

to each Purchaser shall be addressed as set forth on such Purchaser’s respective signature page.

5.5

Amendments; Waivers. No provision of this Agreement may be waived, modified, supplemented, or amended except in a written instrument

signed, in the case of an amendment, by the Company and the Purchasers holding a majority in interest of the Shares then held by all

Purchasers. No waiver of any default with respect to any provision, condition or requirement of this Agreement shall be deemed to be

a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition, or requirement

hereof, nor shall any delay or omission of any party to exercise any right hereunder in any manner impair the exercise of any such right.

5.6

Headings. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to

limit or affect any of the provisions hereof.

5.7

Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and

permitted assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent

of the Purchasers (other than by merger or operation of law). Each Purchaser may assign any or all of its rights under this Agreement

to any Person to whom such Purchaser assigns or transfers any Shares, provided that such transferee agrees in writing to be bound, with

respect to the transferred Shares, by the provisions of the Transaction Documents that apply to such Purchaser.

5.8

No Third-Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective successors

and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, except as otherwise

set forth in Section 4.5.

5.9

Governing Law. This Agreement shall be governed by, and construed in accordance with, the laws of the state of Delaware, without

giving effect to any choice of law or conflict of law rules or provisions (whether of the state of Delaware or any other jurisdiction)

that would cause the application of the laws of any jurisdiction other than the state of Delaware. Any dispute relating hereto shall

be heard first in the Delaware Court of Chancery, and, if applicable, in any state or federal court located in of Delaware in which appeal

from the Court of Chancery may validly be taken under the laws of the State of Delaware (each a “Chosen Court” and

collectively, the “Chosen Courts”), and the parties agree to the exclusive jurisdiction and venue of the Chosen Courts.

The parties further agree that any Proceeding seeking to enforce any provision of, or based on any matter arising out of or in connection

with, this Agreement or the transactions contemplated hereby or by any matters related to the foregoing (the “Applicable Matters”)

shall be brought exclusively in a Chosen Court, and that any Proceeding arising out of this Agreement or any other Applicable Matter

shall be deemed to have arisen from a transaction of business in the state of Delaware, and each of the parties hereby irrevocably consents

to the jurisdiction of such Chosen Courts in any such Proceeding and irrevocably and unconditionally waives, to the fullest extent permitted

by law, any objection that party may now or hereafter have to the laying of the venue of any such Proceeding in any such Chosen Court

or that any such Proceeding brought in any such Chosen Court has been brought in an inconvenient or improper forum. The parties further

covenant not to bring a Proceeding with respect to the Applicable Matters (or that could affect any Applicable Matter) other than in

such Chosen Court and not to challenge or enforce in another jurisdiction a judgment of such Chosen Court. Process in any such Proceeding

may be served on any Person with respect to such Applicable Matters anywhere in the world, whether within or without the jurisdiction

of any such Chosen Court. Without limiting the foregoing, each party agrees that service of process on such party as provided in Section

5.4 shall be deemed effective service of process on such party. IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY

ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW,

HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY.

5.10

Survival. The representations and warranties contained herein shall survive the Closing for a period ending on the one-year anniversary

of the Closing Date.

5.11

Execution. This Agreement may be executed in multiple counterparts, all of which when taken together shall be considered one and

the same agreement and shall become effective when counterparts have been signed by each party and delivered to each other party, it

being understood that the parties need not sign the same counterpart. If any signature is delivered by facsimile transmission or by e-mail

delivery of a “.pdf” format data file, such signature shall create a valid and binding obligation of the party executing

(or on whose behalf such signature is executed) with the same force and effect as if such facsimile or “.pdf” signature page

were an original thereof.

5.12

Severability. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to

be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall

remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially

reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated

by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would

have executed the remaining terms, provisions, covenants, and restrictions without including any of such that may be hereafter declared

invalid, illegal, void or unenforceable.

5.13

Replacement of Securities. If any certificate or book-entry position evidencing any Shares is mutilated, lost, stolen or destroyed,

the Company shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation),

or in lieu of and substitution therefor, a new certificate or book-entry position, but only upon receipt of evidence reasonably satisfactory

to the Company of such loss, theft or destruction. The applicant for a new certificate or book-entry position under such circumstances

shall also pay any reasonable third-party costs (including customary indemnity) associated with the issuance of such replacement Shares.

5.14

Remedies. In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages,

each Purchaser and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that monetary

damages may not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction Documents

and hereby agree to waive and not to assert in any action for specific performance of any such obligation the defense that a remedy at

law would be adequate.

5.15

Payment Set Aside. To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document

or any Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise

or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by

or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law (including,

without limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent of any such

restoration the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect

as if such payment had not been made or such enforcement or setoff had not occurred.

5.16

Saturdays, Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required

or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business

Day.

5.17

Construction. The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise

the Transaction Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against

the drafting party shall not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each

and every reference to share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse

and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the

date of this Agreement.

5.18

Transactions With Counsel. Certain of the Purchasers act as counsel to the Company on certain matters and hereby advise the Company

that certain rules of professional conduct require that the terms of this transaction be fair and reasonable to the Company and be fully

disclosed and transmitted to the Company, and that this Agreement and prior correspondence relating hereto are intended to satisfy that

requirement. The Company acknowledges that it has been advised, and provided with the reasonable opportunity, to seek the advice of independent

counsel (which may include in-house counsel or other counsel of the Company’s choosing) with respect to the transactions contemplated

hereunder, and the Company, by signing below, provides its informed consent to the essential terms of the transactions contemplated hereunder

and that such Purchasers are not acting as counsel to the Company in this transaction.

WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized

signatories as of the date first indicated above.

FUSEMACHINES

INC.

Address

for Notice:

Fusemachines

Inc.

200

West 41st Street, 21st Floor, New York, New York 10036

Attention:

Chief Executive Officer

E-mail:

smaskey@fusemachines.com

By:

Name:

Sameer

Maskey

Title:

Chief

Executive Officer

[REMAINDER

OF PAGE INTENTIONALLY LEFT BLANK

SIGNATURE

PAGES FOR PURCHASERS FOLLOW]

[PURCHASER

SIGNATURE PAGES TO FUSEMACHINES INC. SECURITIES PURCHASE AGREEMENT]

WITNESS WHEREOF, the undersigned has executed this Securities Purchase Agreement as of the day and year first above written.

PURCHASER:

[NAME]

By:

Name:

[●]

Title:

[●]

Address:

[●]

Email:

[●]

Subscription

Amount / Accrued Fees: $[●]

To Be Issued: [●]

[SIGNATURE

PAGES CONTINUE]

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 19

v3.26.3

Cover

Sep. 10, 2026

Document Type

8-K

Amendment Flag

false

Document Period End Date

Sep. 10, 2026

Entity File Number

001-42909

Entity Registrant Name

FUSEMACHINES

INC.

Entity Central Index Key

0002033383

Entity Tax Identification Number

98-1602789

Entity Incorporation, State or Country Code

Entity Address, Address Line One

200

West 41st Street

Entity Address, Address Line Two

21st Floor

Entity Address, City or Town

New

York

Entity Address, State or Province

Entity Address, Postal Zip Code

10036

City Area Code

(347)

Local Phone Number

212-5075

Written Communications

false

Soliciting Material

false

Pre-commencement Tender Offer

false

Pre-commencement Issuer Tender Offer

false

Entity Emerging Growth Company

true

Elected Not To Use the Extended Transition Period

false

Common Stock, par value $0.0001 per share

Title of 12(b) Security

Common

Stock, par value $0.0001 per share

Trading Symbol

FUSE

Security Exchange Name

NASDAQ

Warrants to purchase shares of Common Stock

Title of 12(b) Security

Warrants

to purchase shares of Common Stock

Trading Symbol

FUSEW

Security Exchange Name

NASDAQ

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

Period Type:

duration

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 2 such as Street or Suite number

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine2

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

Period Type:

duration

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 7A

-Section B

-Subsection 2

+ Details

Name:

dei_EntityExTransitionPeriod

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

Period Type:

duration

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

Period Type:

duration

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

Period Type:

duration

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

Period Type:

duration

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Details

Name:

us-gaap_StatementClassOfStockAxis=FUSE_CommonStockParValue0.0001PerShareMember

Namespace Prefix:

Data Type:

Balance Type:

Period Type:

- Details

Name:

us-gaap_StatementClassOfStockAxis=FUSE_WarrantsToPurchaseSharesOfCommonStockMember

Namespace Prefix:

Data Type:

Balance Type:

Period Type: